Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/01/2003US20030082705 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082704 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082703 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082702 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082688 Spoil protein and nucleic acid molecules and uses therefor
05/01/2003US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/01/2003US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
05/01/2003US20030082682 Nucleotide sequences coding polypeptide for use in the treatment cancer, osteoporosis, fertility defects, endometriosis, inflammatory, nervous system, skin and cardiovascular disorders
05/01/2003US20030082681 Nucleic acids, proteins, and antibodies
05/01/2003US20030082680 Candida albicans gene, integrin-like protein, antibodies, and methods of use
05/01/2003US20030082679 Genetically engineered immunoglobulin fusion protein for use in the treatment of neutropenia
05/01/2003US20030082678 Methods and compositions for regulating body weight in bovine species
05/01/2003US20030082677 Nucleotide sequences coding polypeptide for use in the treatment of glucose transport defects
05/01/2003US20030082675 Expression vector for use as gene therapeutic tool
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082671 Method for making acylated polypeptides
05/01/2003US20030082670 Platelet-derived growth factor C, DNA coding therefor, and uses thereof
05/01/2003US20030082660 Orthologues of human receptors and methods of use
05/01/2003US20030082657 Oomycete FtsZ-mt as a target for oomycete-specific antimicrobials
05/01/2003US20030082654 Novel cancer marker and uses therefor in the diagnosis of cancer
05/01/2003US20030082653 Protein for use in the treatment and diagnosis of cancer
05/01/2003US20030082650 Great gene and protein
05/01/2003US20030082648 Novel mass receptor-analogous protein and dnas thereof
05/01/2003US20030082647 Transporter protein
05/01/2003US20030082646 Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL
05/01/2003US20030082645 Nervous system agent for use in the treatment of psychological disorders
05/01/2003US20030082642 Transgenic mammalian cells for use diagnostic tool in monitoring cell activities
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082638 Methods for screening osteogenic compounds
05/01/2003US20030082637 Arrestin gene, polypeptide, and methods of use thereof
05/01/2003US20030082634 Novel cell regulation factor TTO 20
05/01/2003US20030082630 Combinatorial libraries of monomer domains
05/01/2003US20030082629 Screening methods for compounds useful in the regulation of cell proliferation
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082623 Nucleotide sequences coding polypeptide for use in the treatment of depression and psychological disorders
05/01/2003US20030082622 Crystalline polypeptide for use in the treatment of tumor and cardiovascular and respiratory system disorders
05/01/2003US20030082621 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides
05/01/2003US20030082615 Olfactory receptor expression libraries and methods of making and using them
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082611 Methods and compositions for cellular and metabolic engineering
05/01/2003US20030082609 Nuceotide sequences coding polypeptide for use in humans therapeutics and diagnostics
05/01/2003US20030082607 Nucleic acid hairpin probes and uses thereof
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082586 Antibody for use in the diagnosis and treatment of brain tumors, alzhemier's and brain developmental disorders
05/01/2003US20030082585 Novel receptors
05/01/2003US20030082582 Methods for detection of ataxia telangiectasia mutations
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082574 Polyvalent cation-sensing receptor in atlantic salmon
05/01/2003US20030082573 Cell cycle protein
05/01/2003US20030082561 Generation of artifical transcription factor; prepare library of artficial transcription factors, screen library, recover clone demonstrating gene modulation activity, amplify clone
05/01/2003US20030082556 Binary encoded sequence tags
05/01/2003US20030082555 Haplotyping intercellular adhesion molecules; obtain tissue sample, screen form haplotypes, determine presence of haplotype, classify haplotype
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082552 Recovering preferential segment of chromatin; obtain cellular chromatin, incubate with binding agent, map and recover segment of nucleotide sequence bound by agent
05/01/2003US20030082546 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and cancer
05/01/2003US20030082545 Quantitative analysis of cancer-associated mutations; genetic engineering
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082534 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of brain and psychological disorders
05/01/2003US20030082533 Intelectin
05/01/2003US20030082532 Tumor necrosis factor receptor related gene 12 polypeptides
05/01/2003US20030082527 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor
05/01/2003US20030082525 Five-Helix protein
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082521 Polypeptide inducing antibodies neutralizing HIV
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082233 Method and composition for modulating bone growth
05/01/2003US20030082208 Protein having multiple antigen/epitope sequences and being immobilized
05/01/2003US20030082205 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
05/01/2003US20030082204 Mixture of attenuated genetic engineered virus and carrier
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082201 Genetic engineering; polymerase chain reaction
05/01/2003US20030082200 Protein binding to immobilized vitronectin
05/01/2003US20030082199 Compositions and methods for the treatment of immune related diseases
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082196 Anticancer agents